Safety evaluation of a new allergy vaccine containing the adjuvant monophosphoryl lipid A(MPL®) for the treatment of grass pollen allergy

2004 ◽  
Vol 24 (4) ◽  
pp. 261-268 ◽  
Author(s):  
Paul Baldrick ◽  
Derek Richardson ◽  
Alan W. Wheeler ◽  
Stefan R. Woroniecki
Keyword(s):  
Grass Pollen ◽  
Lipid A ◽  
Safety Evaluation ◽  
Pollen Allergy ◽  
Grass Pollen Allergy ◽  
Monophosphoryl Lipid A ◽  
Monophosphoryl Lipid ◽  
Allergy Vaccine

Long-term effect of monophosphoryl lipid A adjuvanted specific immunotherapy in patients with grass pollen allergy

Immunotherapy ◽  
2018 ◽  
Vol 10 (7) ◽  
pp. 529-536 ◽  
Author(s):  
Stefan Zielen ◽  
Jennis Gabrielpillai ◽  
Eva Herrmann ◽  
Johannes Schulze ◽  
Ralf Schubert ◽  
...  
Keyword(s):  
Grass Pollen ◽  
Lipid A ◽  
Specific Immunotherapy ◽  
Pollen Allergy ◽  
Term Effect ◽  
Grass Pollen Allergy ◽  
Monophosphoryl Lipid A ◽  
Monophosphoryl Lipid ◽  
Long Term Effect

scholarly journals Immunotherapy With the PreS-based Grass Pollen Allergy Vaccine BM32 Induces Antibody Responses Protecting Against Hepatitis B Infection

EBioMedicine ◽  
2016 ◽  
Vol 11 ◽  
pp. 58-67 ◽  
Author(s):  
Carolin Cornelius ◽  
Katrin Schöneweis ◽  
Fanny Georgi ◽  
Milena Weber ◽  
Verena Niederberger ◽  
...  
Keyword(s):  
Hepatitis B ◽  
Grass Pollen ◽  
Pollen Allergy ◽  
Antibody Responses ◽  
Hepatitis B Infection ◽  
Grass Pollen Allergy ◽  
Allergy Vaccine
Sign in / Sign up

Export Citation Format

Share Document